Accent Therapeutics
Lexington, Massachusetts, United StatesFounded 201732+ employeesPrivate
$178M raisedGrowth· last: series c (Jan 2024)· 3 rounds
Backed by(13 investors)
Accent is leading the translation of RNA-modifying protein (RMP) biology into promising new therapies by combining a robust chemical biology platform with rigorous approaches to target identification and validation. Our seasoned team of drug developers is uniquely experienced to interrogate and advance small molecule therapies with far-reaching potential.
